Emory University, Atlanta, GA, United States.
American University of Beirut, Beirut, Lebanon.
J Infect Dev Ctries. 2024 Apr 30;18(4):565-570. doi: 10.3855/jidc.17853.
Cytomegalovirus (CMV) infection has long been recognized as an important viral syndrome in the immunocompromised host. The disease is less well described in critically-ill patients. We evaluated the risk factors for the development of CMV infection in patients admitted to the intensive care unit (ICU). We also compared the outcomes of CMV infection in ICU patients to those of patients with hematological malignancies.
This is a retrospective study composed of three arms: patients admitted to the ICU with infection (ICU + / CMV + arm), patients admitted to the ICU who did not develop CMV infection (ICU + / CMV- arm, and patients with hematological malignancies on the hematology ward without CMV infection (ICU - / CMV + arm).
Patients who were admitted to ICU for surgical causes had a decreased risk of CMV infection. On the other hand, receiving corticosteroids and vasoactive drugs was associated with an increased risk of CMV infection with adjusted odds ratios (aOR) of 2.4 and 25.3, respectively. Mortality was higher in ICU + / CMV + patients compared to ICU - / CMV + patients. In the ICU + /CMV + population, male sex and being on mechanical ventilation after CMV infection were independent predictors of mortality (aOR 4.6 and 5.0, respectively).
CMV infection in ICU patients is a potentially serious disease requiring close attention. The findings from our study help in identifying patients in the ICU at risk for CMV infection, thereby warranting frequent screening. Patients at high risk of death (male, on mechanical ventilation) should receive prompt treatment and intensive follow-up.
巨细胞病毒(CMV)感染长期以来被认为是免疫功能低下宿主中重要的病毒综合征。在危重病患者中,这种疾病的描述较少。我们评估了入住重症监护病房(ICU)的患者发生 CMV 感染的危险因素。我们还比较了 ICU 患者 CMV 感染的结果与血液恶性肿瘤患者的结果。
这是一项回顾性研究,由三个部分组成:入住 ICU 并发感染的患者(ICU + / CMV + 组)、入住 ICU 但未发生 CMV 感染的患者(ICU + / CMV- 组)和血液恶性肿瘤患者入住血液科病房且无 CMV 感染的患者(ICU - / CMV + 组)。
因手术原因入住 ICU 的患者发生 CMV 感染的风险降低。另一方面,接受皮质类固醇和血管活性药物与 CMV 感染的风险增加相关,调整后的优势比(aOR)分别为 2.4 和 25.3。与 ICU - / CMV + 患者相比,ICU + / CMV + 患者的死亡率更高。在 ICU + / CMV + 人群中,男性和 CMV 感染后接受机械通气是死亡的独立预测因素(aOR 分别为 4.6 和 5.0)。
ICU 患者的 CMV 感染是一种潜在的严重疾病,需要密切关注。我们的研究结果有助于识别 ICU 中存在 CMV 感染风险的患者,从而需要频繁筛查。高死亡风险的患者(男性、机械通气)应及时接受治疗和密切随访。